Report Summary
Datamonitor's Idenix Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Idenix Pharmaceuticals, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Idenix Pharmaceuticals (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral disease. The company mainly focuses on the development of drugs for the treatment of viral hepatitis and HIV/AIDS. Idenix is headquartered in Cambridge, Massachusetts and employed 144 people as of December 31, 2009. The company recorded revenues of $12.6 million during the financial year (FY) ended December 2009, an increase of 25.5% over FY2008. The operating loss of the company was $54.4 million during FY2009, as compared to an operating loss of $73 million in FY2008. The net loss was $53.2 million in FY2009, as compared to a net loss of $70.2 million in FY2008.
Scope of the Report

• Provides all the crucial information on Idenix Pharmaceuticals, Inc. required for business and competitor intelligence needs
• Contains a study of the major internal and external factors affecting Idenix Pharmaceuticals, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Idenix Pharmaceuticals, Inc.
• Data is supplemented with details on Idenix Pharmaceuticals, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Idenix Pharmaceuticals, Inc.

Reasons to Purchase

• Support sales activities by understanding your customers’ businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors’ business structure, strategy and prospects
• Obtain the most up to date company information available